Taken together, the optimization of the combinatorial tetramer/IL-2:mAb complexes treatment protocol, guided by tetramer analysis, led to the protection against insulitis and to a solid prevention of T1D. This evidence concerns the gene IL2 and type 1 diabetes mellitus.